Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis
Open Access
- 17 March 2004
- journal article
- other
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 63 (6) , 649-655
- https://doi.org/10.1136/ard.2002.004671
Abstract
Objectives: To study the expression of cysteine proteinases, particularly cathepsin K, and their extracellular inhibitor cystatin C in articular cartilage of transgenic Del1 mice which harbour a short deletion mutation in a type II collagen transgene and are predisposed to early onset osteoarthritis. Methods: Northern analysis was used to measure mRNA levels of cathepsins B, H, K, L, and S, and cystatin C in total RNA extracted from knee joints of Del1 mice, using their non-transgenic litter mates as controls. Immunohistochemistry and morphometry was used to study the distribution of cathepsin K and cystatin C in the knee joints. Results: Up regulation of cathepsin K mRNA expression was seen in the knee joints of transgenic Del1 mice at the onset of cartilage degeneration. Cathepsin K was found near sites of matrix destruction in articular chondrocytes, particularly in clusters of proliferating cells, and in calcified cartilaginous matrix. In intact articular cartilage of control animals, cathepsin K was only seen in a small number of chondrocytes. Upon aging, control animals also developed osteoarthritis, which was accompanied by increased cathepsin K expression. Cystatin C was mostly localised in and around chondrocytes located in calcified cartilage, with no obvious association with the onset of cartilage degeneration. Conclusion: The temporospatial distribution of cathepsin K in osteoarthritic cartilage suggests a role for this enzyme in the pathogenesis of osteoarthritis. Because cathepsin K can digest cartilage matrix components it may contribute to the development of osteoarthritic lesions. These data may provide new clues for the development of treatments aimed at preventing cartilage degeneration.Keywords
This publication has 46 references indexed in Scilit:
- Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse modelAnnals of the Rheumatic Diseases, 2002
- Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytesArthritis & Rheumatism, 2001
- Osteoarthritis-like lesions in transgenic mice harboring a small deletion mutation in type II collagen geneOsteoarthritis and Cartilage, 2000
- Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse developmentFEBS Letters, 1996
- Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin b and an inhibitor of matrix metalloproteinases. evidence for two converging pathways of chondrocyte‐mediated proteoglycan degradationArthritis & Rheumatism, 1993
- An inbred line of transgenic mice expressing an internally deleted gene for type II procollagen (COL2A1). Young mice have a variable phenotype of a chondrodysplasia and older mice have osteoarthritic changes in joints.Journal of Clinical Investigation, 1993
- Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain.The Journal of cell biology, 1992
- Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and LFEBS Letters, 1990
- Cathepsin B and cysteine protease inhibitors in human osteoarthritisJournal of Orthopaedic Research, 1990
- Determination of Cathepsins B and H in Sera and Synovial Fluids of Patients with Different Joint Diseasescclm, 1990